Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.
The drug is a generic version of Viatris Inc's Revatio oral suspension.
It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.
